SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 119,600
+200 (0.17%)
Last updated: Jan 29, 2026, 2:14 PM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 9.35 trillion as of January 29, 2026. Its market cap has increased by 7.47% in one year.
Market Cap
9.35T
Enterprise Value
9.16T
Revenue
675.41B
Ranking
n/a
PE Ratio
29.18
Stock Price
119,600.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 9.35T, a decrease of -5.98%. That is a compound annual growth rate of -1.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 9.35T | -4.17% |
| Dec 30, 2025 | 9.76T | 12.15% |
| Dec 30, 2024 | 8.70T | 10.66% |
| Dec 28, 2023 | 7.86T | 39.25% |
| Dec 29, 2022 | 5.65T | -25.82% |
| Dec 30, 2021 | 7.61T | -42.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 21.82T |
| HLB Co., Ltd. | 8.81T |
| LigaChem Biosciences | 7.02T |
| Peptron | 6.69T |
| PharmaResearch | 5.10T |
| D&D Pharmatech | 4.22T |
| SK bioscience | 4.04T |
| Voronoi | 3.85T |